This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Best Growth Stocks to Buy for April 15th
by Zacks Equity Research
OPCH, COMM and JD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 15, 2025.
Best Growth Stocks to Buy for April 11th
by Zacks Equity Research
COMM, JD and BGC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 11, 2025
Why the Market Dipped But JD.com, Inc. (JD) Gained Today
by Zacks Equity Research
The latest trading day saw JD.com, Inc. (JD) settling at $35.58, representing a +1.44% change from its previous close.
Zacks.com featured highlights General Motors, JD.com, Pfizer, StoneCo and Enersys
by Zacks Equity Research
General Motors, JD.com, Pfizer, StoneCo and Enersys have been highlighted in this Screen of The Week article.
5 Low Price-to-Book Stocks to Add to Your Portfolio in April
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, JD, PFE, STNE and ENS are some such stocks.
Best Growth Stocks to Buy for April 8th
by Zacks Equity Research
COMM, RNG and JD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 8, 2025.
JD.com (JD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
JD.com (JD) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Is Trending Stock JD.com, Inc. (JD) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to JD.com (JD). This makes it worthwhile to examine what the stock has in store.
4 PEG-Based Value Stocks to Buy Amid Tariff War and Market Bloodbath
by Urmimala Biswas
Here are four PEG-driven value stocks that fit our screening criteria. These are QFIN, SUZ, FMS and JD.
PDD vs. JD: Which Chinese E-Commerce Stock Is the Better Buy?
by Vasundhara Sawalka
JD.com offers expanding margins, stronger valuation and stable returns, making it the preferred Chinese e-commerce play over PDD Holdings' uncertain growth strategy.
Best Growth Stocks to Buy for April 3rd
by Zacks Equity Research
COMM, OPCH, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 3, 2025.
JD.com Rises 49% in a Year: Should Investors Buy the Stock Now?
by Zacks Equity Research
JD integrates AI into its operations while expanding other verticals, including retail, presenting a compelling entry point for investors now.
Wall Street Analysts See a 28.75% Upside in JD.com (JD): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for JD.com (JD) points to a 28.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Best Growth Stocks to Buy for April 1st
by Zacks Equity Research
COMM, OPCH, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 1, 2025.
JD.com, Inc. (JD) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the latest trading session, JD.com, Inc. (JD) closed at $41.12, marking a -1.11% move from the previous day.
JD or EBAY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
JD vs. EBAY: Which Stock Is the Better Value Option?
Should Value Investors Buy JD.com (JD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Retail-Wholesale Stocks Lagging JD.com (JD) This Year?
by Zacks Equity Research
Here is how JD.com, Inc. (JD) and LY Corporation Unsponsored ADR (YAHOY) have performed compared to their sector so far this year.
Zacks.com featured highlights include JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology
by Zacks Equity Research
JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology are part of the Zacks Screen of the Week article.
A Key March Nonfarm Job Report is Coming
by John Blank
Will it show big DOGE Federal job cuts?
4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns
by Urmimala Biswas
Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN.
Best Growth Stocks to Buy for March 28th
by Zacks Equity Research
COMM, DAN, and JD it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 28, 2025.
Zacks.com featured highlights JD.com, City Office REIT, Fresenius Medical Care, Itron and Enersys
by Zacks Equity Research
JD.com, City Office REIT, Fresenius Medical Care, Itron and Enersys have been highlighted in this Screen of The Week article.
3 Key Reasons to Buy JD.com Stock Beyond the 52.8% Surge in a Year
by Vasundhara Sawalka
JD's 52% surge, 8.58X P/E and global expansion make it a must-buy. With AI innovation and UEFA partnership, this e-commerce leader is set for 2025 growth.
JD.com (JD) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in JD.com (JD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?